|
 |
|
|||||||
|
|||||||||
Diabetes 51:1655-1662, 2002
© 2002 by the American Diabetes Association, Inc.
Perspectives in Diabetes |
Genetic Studies of Late Diabetic Complications
The Overlooked Importance of Diabetes Duration Before Complication Onset
1 Research Division, Joslin Diabetes Center, Boston, Massachusetts
2 Department of Medicine, Harvard Medical School, Boston, Massachusetts
3 Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts
Genes play a role in many processes underlying late diabetic complications, but efforts to identify genetic variants have produced disappointing and contradictory results. Here, we evaluate whether the study designs and analytic methods commonly being used are optimal for finding susceptibility genes for diabetic complications. We do so by generating plausible genetic models and assessing the performance of case-control and family-based trio study designs. What emerges as a key determinant of success is duration of diabetes. This perspective focuses on duration of diabetes before complication onset and its influence on the ability to detect major and minor gene effects. It does not delve into the distinct effect of duration after complication onset, which can enrich case subjects with genotypes conferring survival advantage. We use clinically diagnosed nephropathy in type 1 diabetes to show how ignoring duration can result in considerable power loss in both case-control and family-based trio designs. We further show how, under certain circumstances, disregard for duration information can paradoxically lead to implicating nonrisk alleles as causative. Our results indicate that problems can be minimized by selecting case subjects with short diabetes duration and, to a lesser extent, control subjects with long duration or, perhaps, by adjusting for duration during analysis.
CiteULike 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  S. J.L. Bakker, A. Alkhalaf, L. Tarnow, and G. Navis Comment on: Wanic et al. (2008) Exclusion of Polymorphisms in Carnosinase Genes (CNDP1 and CNDP2) as a Cause of Diabetic Nephropathy in Type 1 Diabetes: Results of Large Case-Control and Follow-Up Studies: Diabetes 57:2547-2551, 2008 Diabetes, December 1, 2008; 57(12): e16 - e16. [Full Text] [PDF]
|
|
|
|
|
|
K. Wanic, G. Placha, J. Dunn, A. Smiles, J. H. Warram, and A. S. Krolewski Exclusion of Polymorphisms in Carnosinase Genes (CNDP1 and CNDP2) as a Cause of Diabetic Nephropathy in Type 1 Diabetes: Results of Large Case-Control and Follow-Up Studies Diabetes, September 1, 2008; 57(9): 2547 - 2551. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Rogus, G. D. Poznik, M. G. Pezzolesi, A. M. Smiles, J. Dunn, W. Walker, K. Wanic, D. Moczulski, L. Canani, S. Araki, et al. High-Density Single Nucleotide Polymorphism Genome-Wide Linkage Scan for Susceptibility Genes for Diabetic Nephropathy in Type 1 Diabetes: Discordant Sibpair Approach Diabetes, September 1, 2008; 57(9): 2519 - 2526. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. K. Cordovado, Y. Zhao, J. H. Warram, H. Gong, K. L. Anderson, M. M. Hendrix, L. N. Hancock, P. A. Cleary, and P. W. Mueller Nephropathy in Type 1 Diabetes Is Diminished in Carriers of HLA-DRB1*04: The Genetics of Kidneys in Diabetes (GoKinD) Study Diabetes, February 1, 2008; 57(2): 518 - 522. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Schelling, H. E. Abboud, S. B. Nicholas, M. V. Pahl, J. R. Sedor, S. G. Adler, N. H. Arar, D. W. Bowden, R. C. Elston, B. I. Freedman, et al. Genome-Wide Scan for Estimated Glomerular Filtration Rate in Multi-Ethnic Diabetic Populations: The Family Investigation of Nephropathy and Diabetes (FIND) Diabetes, January 1, 2008; 57(1): 235 - 243. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Thamotharampillai, A. K.F. Chan, B. Bennetts, M. E. Craig, J. Cusumano, M. Silink, P. J. Oates, and K. C. Donaghue Decline in Neurophysiological Function After 7 Years in an Adolescent Diabetic Cohort and the Role of Aldose Reductase Gene Polymorphisms. Diabetes Care, September 1, 2006; 29(9): 2053 - 2057. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. W. Mueller, J. J. Rogus, P. A. Cleary, Y. Zhao, A. M. Smiles, M. W. Steffes, J. Bucksa, T. B. Gibson, S. K. Cordovado, A. S. Krolewski, et al. Genetics of Kidneys in Diabetes (GoKinD) Study: A Genetics Collection Available for Identifying Genetic Susceptibility Factors for Diabetic Nephropathy in Type 1 Diabetes J. Am. Soc. Nephrol., July 1, 2006; 17(7): 1782 - 1790. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Qi, H. Fujita, J. Jin, L. S. Davis, Y. Wang, A. B. Fogo, and M. D. Breyer Characterization of Susceptibility of Inbred Mouse Strains to Diabetic Nephropathy Diabetes, September 1, 2005; 54(9): 2628 - 2637. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Taverna, J.-L. Selam, and G. Slama Association between a Protein Polymorphism in the Start Codon of the Vitamin D Receptor Gene and Severe Diabetic Retinopathy in C-Peptide-Negative Type 1 Diabetes J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4803 - 4808. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Baum, M. C.Y. Ng, W.-Y. So, V. K.L. Lam, Y. Wang, E. Poon, B. Tomlinson, S. Cheng, K. Lindpaintner, and J. C.N. Chan Effect of Hepatic Lipase -514C->T Polymorphism and Its Interactions With Apolipoprotein C3 -482C->T and Apolipoprotein E Exon 4 Polymorphisms on the Risk of Nephropathy in Chinese Type 2 Diabetic Patients Diabetes Care, July 1, 2005; 28(7): 1704 - 1709. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. J. Pettersson-Fernholm, C. M. Forsblom, M. Perola, J. A. Fagerudd, and P.-H. Groop Dopamine D3 receptor gene polymorphisms, blood pressure and nephropathy in type 1 diabetic patients Nephrol. Dial. Transplant., June 1, 2004; 19(6): 1432 - 1436. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Omori, K. Naruishi, F. Nishimura, H. Yamada-Naruishi, and S. Takashiba High Glucose Enhances Interleukin-6-induced Vascular Endothelial Growth Factor 165 Expression via Activation of Gp130-mediated p44/42 MAPK-CCAAT/Enhancer Binding Protein Signaling in Gingival Fibroblasts J. Biol. Chem., February 20, 2004; 279(8): 6643 - 6649. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-i. Araki, D. P.K. Ng, B. Krolewski, L. Wyrwicz, J. J. Rogus, L. Canani, Y. Makita, M. Haneda, J. H. Warram, and A. S. Krolewski Identification of a Common Risk Haplotype for Diabetic Nephropathy at the Protein Kinase C-{beta}1 (PRKCB1) Gene Locus J. Am. Soc. Nephrol., August 1, 2003; 14(8): 2015 - 2024. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Diabetes | Diabetes Care | Clinical Diabetes | Diabetes Spectrum |